A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
批准号:
9085455
负责人:
ANDREW J LEVINE
金额:
$32.27万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-06 至 2018-05-31
关键词:
AffectAgeAlcohol or Other Drugs useAnti-Retroviral AgentsAstrocytesBehaviorBrainBrain regionCharacteristicsChronicClinicalCognitiveCollaborationsDementiaDiseaseEpidemiologyEquationEventExogenous FactorsFutureGenesGeneticGenetic Predisposition to DiseaseGenotypeHIVHIV-associated neurocognitive disorderHepatitis CHippocampus (Brain)ImageImmunohistochemistryImpairmentIndividualInfectionInfiltrationInfluentialsInternationalLeadLinkMeasuresMissionModelingMolecularNatureNeurocognitiveNeurocognitive DeficitNeuropathogenesisOutcomeOutcome StudyPaperPathogenesisPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePhenotypePhysiologicalPrevalenceProceduresQuality of lifeRegression AnalysisResearchResourcesRiskSamplingSeveritiesSusceptibility GeneSynapsesSystemUnited StatesUnited States National Institutes of HealthUniversitiesVariantViral Load resultabeta depositionantiretroviral therapybasebehavioral impairmentbehavioral outcomebrain tissuecase controlclinical Diagnosiscohortdesignfrontal lobefunctional disabilitygene productgenetic risk factorgenetic variantimmune activationimprovedinnovationmacrophagemeetingsneuroAIDSneurobehavioralneuroinflammationneuropathologyputamen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The prevalence of HIV-associated neurocognitive disorders (HAND) is near 50% despite the widespread use of combined antiretroviral therapy (cART). HAND is a clinical diagnosis based on neurocognitive impairments ranging in severity from mild neurocognitive deficits to a debilitating dementia. HAND is the result of a chronic neuroinflammatory state fueled by host immune activation; however, the key pathophysiological pathways involved remain unclear. In recent years, a small number of host genetic susceptibility loci have been identified that increase risk for HAND or influence its course, suggesting that perturbation of the physiological pathways their gene products are involved in modifies HAND pathogenesis. However, all studies of HAND-related genetic susceptibility loci have relied solely on clinical outcomes; nothing is known of what pathophysiological changes these genetic variants cause. An innovative approach for determining the pathophysiological mechanisms through which genetic susceptibility loci influence HAND is to examine their influence on neuropathological intermediate phenotypes, or NIPs. At its most basic level, HAND is believed to be the end result of a sequence of physiological events that commences with HIV-induced cellular changes that are modified by genetic factors. In the context of the present study, we deem quantifiable neuropathological changes that occur proximal to the beginning of this causal chain of HAND pathogenesis as the NIPs necessary for the behavioral impairments characteristic of HAND. There exist a number of candidate NIPs that are associated with HAND, including synaptodendritic simplification; macrophage infiltration; microglial and astrocyte activation, and beta-amyloid deposition. Through examining the relationship between genetic susceptibility loci and NIPs in brain tissue derived from a clinically well-characterized cohort, it will be possible t determine 1) which genetic variants are biologically relevant to HAND, 2) the pathophysiological mechanisms through which they exert their effect on the neurobehavioral phenotypes, and 3) the relative importance of NIPs as underlying causative factors of HAND. This study is highly relevant to the mission of NIH to elucidate the physiological mechanisms leading to HAND. To accomplish our aims, we will use immunohistochemistry and high throughput quantification procedures to characterize NIPs across multiple brain regions. Our aim is to determine the extent to which genotype and important co-factors (e.g., age, substance use, cART use) modify these NIPs. Our second aim will determine the linear causative relationship between genetic susceptibility loci, NIPs, and neurocognitive impairment. Towards this end we will use Network Edge Orienting to determine the causative relationship between genotype and NIPs. This will be integrated with structural equation modeling, thus allowing creation of a comprehensive pathway model of HAND that includes genotype, NIPs, neurocognitive functioning, and important co-factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Causes and consequences of suboptimal cognitive effort in the MACS
-
批准号:9789986
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2018
-
负责人:ANDREW J LEVINE
-
依托单位:
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
-
批准号:8411068
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2012
-
负责人:ANDREW J LEVINE
-
依托单位:
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
-
批准号:8871792
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2012
-
负责人:ANDREW J LEVINE
-
依托单位:
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
-
批准号:8541049
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2012
-
负责人:ANDREW J LEVINE
-
依托单位:
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
-
批准号:8695488
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2012
-
负责人:ANDREW J LEVINE
-
依托单位:
The impact of host genetics and stimulant use on neurocognition in HIV+ adults.
-
批准号:7588412
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2008
-
负责人:ANDREW J LEVINE
-
依托单位:
The impact of host genetics and stimulant use on neurocognition in HIV+ adults.
-
批准号:7674588
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2008
-
负责人:ANDREW J LEVINE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: